Evidence map›Paper›PMID 19901985›Full record

ArticlePloS one2009

Acute inhibition of selected membrane-proximal mouse T cell receptor signaling by mitochondrial antagonists.

Kwangmi Kim, Lin Wang, Inkyu Hwang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kwangmi KimDepartment of Chemistry and Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
Lin Wang
Inkyu Hwang
Scripps Research Institute · US

Funding

Development of Immune Modulators via Chemical GeneticsR01AI066146 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI HWANG, INKYU · 2006 to 2008
$1.4M
Development of Immune Modulators via Chemical GeneticsR56AI066146 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI HWANG, INKYU · 2009 to 2009
$475k
NIAID NIH HHS AI066146NIAID NIH HHS R01 AI066146NIAID NIH HHS R56 AI066146
6 · The paper itself

Abstract

T cells absorb nanometric membrane vesicles, prepared from plasma membrane of antigen presenting cells, via dual receptor/ligand interactions of T cell receptor (TCR) with cognate peptide/major histocompatibility complex (MHC) plus lymphocyte function-associated antigen 1 (LFA-1) with intercellular adhesion molecule 1. TCR-mediated signaling for LFA-1 activation is also required for the vesicle absorption. Exploiting those findings, we had established a high throughput screening (HTS) platform and screened a library for isolation of small molecules inhibiting the vesicle absorption. Follow-up studies confirmed that treatments (1 hour) with various mitochondrial antagonists, including a class of anti-diabetic drugs (i.e., Metformin and Phenformin), resulted in ubiquitous inhibition of the vesicle absorption without compromising viability of T cells. Further studies revealed that the mitochondrial drug treatments caused impairment of specific membrane-proximal TCR signaling event(s). Thus, activation of Akt and PLC-gamma1 and entry of extracellular Ca(2+) following TCR stimulation were attenuated while polymerization of monomeric actins upon TCR triggering progressed normally after the treatments. Dynamic F-actin rearrangement concurring with the vesicle absorption was also found to be impaired by the drug treatments, implying that the inhibition by the drug treatments of downstream signaling events (and the vesicle absorption) could result from lack of directional relocation of signaling and cell surface molecules. We also assessed the potential application of mitochondrial antagonists as immune modulators by probing effects of the long-term drug treatments (24 hours) on viability of resting primary T cells and cell cycle progression of antigen-stimulated T cells. This study unveils a novel regulatory mechanism for T cell immunity in response to environmental factors having effects on mitochondrial function.

Indexed as

ActinsAnimalsCalciumCell CycleCell MembraneCell ProliferationMajor Histocompatibility ComplexMiceMice, Inbred C57BLMitochondriaPhospholipase C gammaPhosphorylationReceptors, Antigen, T-CellSignal TransductionT-LymphocytesActinsCalciumPhospholipase C gammaReceptors, Antigen, T-Cell

Identifiers

PMID19901985
PMCPMC2768903
OpenAlexW2036650587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.